GeneThera, Inc.

GTHR · OTC
Analyze with AI
12/31/2021
12/31/2020
12/31/2019
12/31/2018
Operating Activities
Net Income-$1,011-$774-$518-$3,396
Dep. & Amort.$5$5$5$5
Deferred Tax$0$0$0$0
Stock-Based Comp.$0$15$0$2,932
Change in WC$488$749$513$645
Other Non-Cash$510$0$0-$648
Operating Cash Flow-$9-$5$0-$463
Investing Activities
PP&E Inv.$0$0$0$0
Net Acquisitions$0$0$0$0
Inv. Purchases$0$0$0$0
Inv. Sales/Matur.$0$0$0$0
Other Inv. Act.$0$0$0$0
Investing Cash Flow$0$0$0$0
Financing Activities
Debt Repay.$5$0$0$0
Stock Issued$3$0$0$300
Stock Repurch.$0$0$0$0
Dividends Paid$0$0$0$0
Other Fin. Act.$0$0$0$0
Financing Cash Flow$9$0$0$300
Forex Effect$0$0$0$0
Net Chg. in Cash$0-$5$0-$163
Supplemental Information
Beg. Cash$0$5$5$168
End Cash$0$0$5$5
Free Cash Flow-$9-$5$0-$463
GeneThera, Inc. (GTHR) Financial Statements & Key Stats | AlphaPilot